Chemocentryx Inc (CCXI)
51.99 +0.03 (+0.06%) 10/20/22 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
for Wed, Oct 19th, 2022
Results
download Want to compare other data? Select Fields| Symbol | CCXI | IONS | SLNO | ||
| Company | Chemocentryx Inc | Ionis Pharmaceuticals | Soleno Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 51.98 | 29.75 | 72.75 | ||
| High | 52.00 | 30.08 | 74.25 | ||
| Low | 51.98 | 29.48 | 71.24 | ||
| Last | 51.99 | 29.74 | 73.64 | ||
| Change | +0.03 | +0.04 | +0.38 | ||
| % Change | +0.06% | +0.13% | +0.52% | ||
| Volume | 2,480,300 | 1,652,700 | 904,400 | ||
| 20-Day Average Volume | 1,231,860 | 1,926,890 | 1,553,930 | ||
| Previous Close | 51.96 | 29.70 | 73.26 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 51.83 | 28.33 | 69.45 | ||
| 20-Day Raw Stochastic | 97.78% | 88.67% | 95.08% | ||
| 20-Day Relative Strength | 79.02% | 48.78% | 63.88% | ||
| Weighted Alpha | +1.40 | -32.09 | +39.61 | ||
| Today's Opinion | 100% Buy | 88% Sell | 100% Buy | ||
| Previous Opinion | 100% Buy | 88% Sell | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 80% Sell | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.08% since 10/12/22 | +4.31% since 04/21/25 | +6.83% since 04/21/25 | ||
| Low | 51.90 on 10/13/22 | 28.46 on 04/22/25 | 69.10 on 04/22/25 | ||
| High | 52.00 on 10/19/22 | 30.12 on 04/23/25 | 74.50 on 04/23/25 | ||
| 1-Month | |||||
| %Chg | +0.83% since 09/19/22 | -4.53% since 03/28/25 | +2.29% since 03/28/25 | ||
| Low | 51.55 on 09/23/22 | 23.95 on 04/09/25 | 57.01 on 04/09/25 | ||
| High | 52.00 on 10/19/22 | 30.48 on 03/31/25 | 74.50 on 04/23/25 | ||
| 3-Month | |||||
| %Chg | +120.86% since 07/19/22 | -12.81% since 01/28/25 | +50.35% since 01/28/25 | ||
| Low | 21.87 on 07/25/22 | 23.95 on 04/09/25 | 43.00 on 03/11/25 | ||
| High | 52.00 on 10/19/22 | 35.00 on 03/06/25 | 74.50 on 04/23/25 | ||
| 6-Month | |||||
| %Chg | +145.24% since 04/19/22 | -26.31% since 10/28/24 | +33.14% since 10/28/24 | ||
| Low | 14.95 on 05/09/22 | 23.95 on 04/09/25 | 41.50 on 01/15/25 | ||
| High | 52.00 on 10/19/22 | 40.58 on 10/29/24 | 74.50 on 04/23/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,709,799 | 4,306,362 | 3,367,792 | ||
| Shares Outstanding, K | 71,356 | 158,965 | 49,908 | ||
| Annual Sales | 32,220,000 | 705,140,000 | 0 | ||
| Annual Net Income | -131,760,000 | -453,900,000 | -175,850,000 | ||
| Last Quarter Sales | 11,760,000 | 226,580,000 | 0 | ||
| Last Quarter Net Income | -31,650,000 | -104,350,000 | -55,980,000 | ||
| 60-Month Beta | 1.22 | 0.29 | -2.29 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.44 on 08/09/22 | -0.66 on 02/19/25 | -1.27 on 02/27/25 | ||
| Latest Earnings Date | 11/08/22 | 04/30/25 | 05/07/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||